View in EDS HTML Full Text PDF Full Text

Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors.

Saved in:
Bibliographic Details
Title: Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors.
Authors: Senent, Yaiza1,2,3 (AUTHOR), Fresquet, Vicente2,4 (AUTHOR) vfresquet@unav.es, Jiménez, Victoria2,4 (AUTHOR), Valencia, Karmele1,2,3,5 (AUTHOR), Exposito, Francisco1,2,5,6 (AUTHOR), Martín-Úriz, Patxi San2,4 (AUTHOR), Camps, Gracián1 (AUTHOR), Fernández-Pierola, Eva1 (AUTHOR), de Córdoba, Borja Ruiz-Fernández1 (AUTHOR), González-Huarriz, Marisol1,2,7 (AUTHOR), Tamayo, Ibon8 (AUTHOR), Remírez, Ana1,2,5 (AUTHOR), Moreno, Haritz1 (AUTHOR), Serrano, Diego1,2,5,6 (AUTHOR), Ajona, Daniel1,2,3,5 (AUTHOR), Alonso, Marta M.1,2,7 (AUTHOR), Lecanda, Fernando1,2,5,6 (AUTHOR), Pineda-Lucena, Antonio9 (AUTHOR), Prósper, Felipe2,4,5,10 (AUTHOR), Sanmamed, Miguel F.1,2,5,11 (AUTHOR)
Source: Molecular Cancer. 5/30/2025, Vol. 24 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-025-02352-4